Formoterol For Asthma: Evidence Of Serious Adverse Effects
Thursday, October 16, 2008 - 17:14
in Health & Medicine
Asthma sufferers who regularly take the beta2-agonist formoterol are more likely to suffer non-fatal serious adverse events than those given placebos. A review carried out by Cochrane researchers showed a significantly increased risk for people who took the drug once or twice daily for at least 12 weeks.
Read the whole article on Science Daily
More from Science Daily
Related
- Formoterol for asthma: Evidence of serious adverse effectsTue, 7 Oct 2008, 19:57:17 EDT
- Regular salmeterol for asthma: More evidence of long-term problemsThu, 17 Jul 2008, 11:43:07 EDT
- Asthma: Commonly used medication shows no clear benefits in childrenWed, 10 Dec 2008, 4:08:57 EST
- Medicines derived from cannabis: a review of adverse eventsMon, 16 Jun 2008, 17:22:11 EDT
- International Serious Adverse Events Consortium announces initial study results in its global research collaboration to identify genetic markers related to drug induced liver injurySun, 31 May 2009, 14:36:33 EDT